AI assistant
Sending…
Armata Pharmaceuticals, Inc. — Director's Dealing 2003
Feb 7, 2003
34152_dirs_2003-02-07_b8e6b19d-aed3-4ab1-91eb-3b6ada24ea42.zip
Director's Dealing
Open in viewerOpens in your device viewer
4 1 targetedf4.htm 3: Form 4
| Form 4 | OMB APPROVAL | |
|---|---|---|
| OMB Number: 3235-0287 | ||
| Expires: January 31, 2005 | ||
| [ ] | Check box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See instructions 1(b). | Estimated average burden hours per response. . . 0.5 |
| Name and Address of Reporting Person* Capital Technologies CDPQ inc.(formerly Sofinov, Société financière d'innovation inc.) | 2. Issuer Name and Ticker or Trading Symbol Targeted Genetics Corp, Inc. | 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) __ Director X 10% Owner __ Officer (give ___ Other (specify title below) below) Chief Financial Officer and Chief Strategy Officer 55: | |
|---|---|---|---|
| (Last) (First) (Middle) 1981 Mc Gill College | 3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary) | 4. Statement for Month/Day/Year 01/22/03 | |
| (Street) Montreal (Quebec) Canada H3A 3C7 | 5. If Amendment, Date of Original (Month/Day/Year) | 7. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person ___ Form filed by More than One Reporting Person | |
| (City) (State) (Zip) | Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
| Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned at End of Month (Instr. 3 and 4) | 6. Owner- ship Form: Direct (D) or Indirect (I) (Instr. 4) | |||
|---|---|---|---|---|---|---|---|---|
| Code | V | Amount | (A) or (D) | Price | ||||
| Common shares | 01/22/03 | S | 200 000 | D | Can $ 85 845 US $ 56 000 | 2 266 667 | D |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instructions 4(b)(v). |
|---|
| (Over) SEC 1474 (3-99) |
FORM 4 (continued) Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
| 1.Title of Derivative Security (Instr.3) — Code |
|---|
| Stock Options (right to buy) |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
|---|---|
| Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Page 2
More from Armata Pharmaceuticals, Inc.
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 27
Regulatory Filings
2026
Apr 27
Annual Report
2026
Mar 25
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Feb 23